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absent from dbSNP and 1000 Genomes data, that we
propose to be a cause of BVVL.We also describe the clinical
and genetic heterogeneity that is present in BVVL.
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To the Editor: Johnson et al. report that a secondmutation
in C20orf54 (MIM *613350) is seen in their BVVLS family
‘‘2008,’’ which appears to be the same individual as our
‘‘case 4,’’1 implying that this patient is a compound hetero-
zygote (p.E71K and p.Y213X) rather than homozygous for
Y213X. Upon reexamination of the sequence traces, even
with the benefit of hindsight, we still see a homozygous
change at Y213X, although we do see a heterozygous
change at E71K. We concur that this patient is most likely
a compound heterozygote on the basis of the results of
Johnson et al. This clearly demonstrates the advantage of
testing additional family members, including parents
whom we did not have access to at the time of paper
submission.
We can confirm that we have also identified the homo-
zygous mutation p.P28T in a sample provided to us by
H. Houlden, which appears to be the second BVVLSpatient reported by Johnson et al. (sample 48111). This
result was not published in our report.1
We read with interest the exome-sequencing data the
authors provide in their Letter. Before we submitted our
paper, Dr. Singleton, upon learning that we had identified
mutations in our BVVLS patients, provided us with a short
list of 364 variants in 223 candidate genes from his study.
Neither c20orf54, nor the other four genes mentioned in
their letter appeared in this short list. The approach of
whole-exome sequencing for determining causative muta-
tions in rare monogenic disorders is one of the many
exciting developments of next-generation sequencing.2
It is currently still a very expensive, sledgehammer
approach, which will undoubtedly become more cost
effective in the near future. Some of the pitfalls demon-
strated by Johnson et al. may also be ameliorated by tech-
nical improvements. Notably, sequencing several patients,
filtering by dbSNP, and shortlistingmutations that occur in
all patients may yield confusing results if, as in thean Journal of Human Genetics 87, 567–570, October 8, 2010 569
Johnson et al. study, one of the patients does not have
a point mutation in the candidate gene.
Dragana Josifova,1 Matthew Wiseman,2
and Peter Green2,*
1Department of Clinical Genetics, Guy’s Hospital, London
SE1 9RT, UK; 2Department of Medical and Molecular
Genetics, Kings College, London SE1 9RT, UK
*Correspondence: peter.green@kcl.ac.uk
Web Resources
The URL for data presented herein is as follows:
Online Mendelian Inheritance in Man (OMIM), http://www.ncbi.
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